L19TNFα in Combination With Doxorubicin in Patients With Advanced Solid Tumours
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Advanced Solid Tumors Amenable to Anthracycline Therapy|Sarcoma, Breast Cancer, Lung Carcinomas, and Gynecological Cancer Amenable to Anthracycline Therapy
Interventions: DRUG: L19TNFα|DRUG: Doxorubicin
Sponsor: Philogen S.p.A.